China NT Pharma Group Company Limited 

HK$0.4200
2
+HK$0.06+16.67% Thursday 07:59

Statistics

Day High
0.42
Day Low
0.42
52W High
1.2
52W Low
0.3
Volume
50,000
Avg. Volume
253,294
Mkt Cap
283.18M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Dividends

0%Dividend Yield
Aug 18
HK$0.35
Jul 17
HK$0.25
Jun 16
HK$0.10
10Y Growth
N/A
5Y Growth
N/A
3Y Growth
N/A
1Y Growth
N/A

Earnings

29MarExpected
Q2 2022
Q3 2022
Q4 2022
Q1 2023
Q2 2023
Q3 2023
Q4 2023
0
0.33
0.67
1
Expected EPS
0
Actual EPS
0

Financials

-108.44%Profit Margin
Unprofitable
2020
2021
2022
2023
2024
2025
26.68MRevenue
-28.93MNet Income

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Sinopharm Group
1099.HK
Mkt Cap63.51B
Sinopharm Group Co. Ltd. is a direct competitor in the pharmaceutical distribution and retail sector in China, similar to China NT Pharma.
China Resources Pharmaceutical Group Limited
3320.HK
Mkt Cap42.41B
Shanghai Pharmaceuticals Holding Co. Ltd. competes in both pharmaceutical manufacturing and distribution, overlapping with China NT Pharma's market.
Sino Biopharmaceutical
1177.HK
Mkt Cap85.6B
Sino Biopharmaceutical Ltd. operates in the pharmaceutical sector in China, producing and distributing products that compete with those of China NT Pharma.
Shanghai Pharmaceuticals.
2607.HK
Mkt Cap76.63B
Shanghai Fosun Pharmaceutical Group Co. Ltd. is involved in pharmaceutical manufacturing and healthcare services, competing in similar segments as China NT Pharma.
3SBIO
1530.HK
Mkt Cap20.36B
3SBio Inc. focuses on biotechnology and pharmaceutical products in China, competing in the innovative drug market where China NT Pharma is also present.
SSY Group Limited
2005.HK
Mkt Cap12.13B
China Medical System Holdings Limited markets and distributes pharmaceutical products, directly competing with China NT Pharma's distribution business.
Shanghai Fosun Pharmaceutical (Group).
2196.HK
Mkt Cap104.44B
Luye Pharma Group Ltd. specializes in the development, production, and sale of pharmaceutical products in China, competing in similar therapeutic areas as China NT Pharma.
Ping An Healthcare And Technology Company Limited
1833.HK
Mkt Cap34.91B
Shandong Weigao Group Medical Polymer Company Limited specializes in the manufacture and sale of medical products, competing indirectly in the healthcare sector.
Hansoh Pharmaceutical Group Company Limited
3692.HK
Mkt Cap90.49B
Hansoh Pharmaceutical Group Company Limited, which operates in the pharmaceutical sector in China, offers products that compete with China NT Pharma's offerings.
Ascletis Pharma
1672.HK
Mkt Cap3.89B
Ascletis Pharma Inc. focuses on developing innovative drugs in China, competing with China NT Pharma's efforts in the pharmaceutical innovation space.

About

China NT Pharma Group Company Limited, operating alongside its various subsidiaries, is dedicated to the full spectrum of pharmaceutical activities. This encompasses the research, development, manufacturing, commercialization, and distribution of medicinal products, serving both the People's Republic of China and international territories. The firm develops and markets prescription medications addressing a diverse array of medical conditions, including oncological and hematological diseases, gastrointestinal disorders, central nervous system afflictions, and respiratory illnesses, among other therapeutic fields. In addition to these specialized drugs, it also produces and distributes its proprietary "NT" branded products and generic formulations. Furthermore, the group extends its offerings to include marketing and promotional assistance for suppliers, alongside providing logistics and consulting solutions. Established in 1995, the company maintains its corporate headquarters in Suzhou, People's Republic of China.
Show more...
CEO
Bozhi Zhang
Employees
22
Country
Cayman Islands
ISIN
KYG2114L1133

Listings

0 Comments

Share your thoughts

FAQ

What is China NT Pharma Group Company Limited stock price today?
The current price of 1011.HK is HK$0.42 HKD — it has increased by +16.67% in the past 24 hours. Watch China NT Pharma Group Company Limited stock price performance more closely on the chart.
What is China NT Pharma Group Company Limited stock ticker?
Depending on the exchange, the stock ticker may vary. For instance, on Hong Kong Exchange exchange China NT Pharma Group Company Limited stocks are traded under the ticker 1011.HK.
Is China NT Pharma Group Company Limited stock price growing?
1011.HK stock has risen by +18.31% compared to the previous week, the month change is a +31.25% rise, over the last year China NT Pharma Group Company Limited has showed a -61.47% decrease.
What is China NT Pharma Group Company Limited market cap?
Today China NT Pharma Group Company Limited has the market capitalization of 283.18M
What were China NT Pharma Group Company Limited earnings last quarter?
1011.HK earnings for the last quarter are 0 HKD per share, whereas the estimation was 0 HKD resulting in a +NaN% surprise. The estimated earnings for the next quarter are N/A HKD per share.
What is China NT Pharma Group Company Limited revenue for the last year?
China NT Pharma Group Company Limited revenue for the last year amounts to 26.68M HKD.
What is China NT Pharma Group Company Limited net income for the last year?
1011.HK net income for the last year is -28.93M HKD.
Does China NT Pharma Group Company Limited pay dividends?
Yes, 1011.HK dividends are paid annual. The last dividend per share was 0.35 . As of today, Dividend Yield (FWD)% is 0%.
How many employees does China NT Pharma Group Company Limited have?
As of September 19, 2026, the company has 22 employees.
In which sector is China NT Pharma Group Company Limited located?
China NT Pharma Group Company Limited operates in the Health & Wellness sector.
When did China NT Pharma Group Company Limited complete a stock split?
The last stock split for China NT Pharma Group Company Limited was on July 03, 2024 with a ratio of 1:10.
Where is China NT Pharma Group Company Limited headquartered?
China NT Pharma Group Company Limited is headquartered in Hong Kong, Cayman Islands.